An interventional study of Posterior tibial nerve stimulation and Sham posterior tibial nerve stimulation in Colorectal Surgery, sponsored by Hospital Universitari Vall d'Hebron Research Institute. Completed at 2 sites in Spain. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2019-11-29.
Sponsored by Hospital Universitari Vall d'Hebron Research Institute · Not applicable, Interventional, and Supportive care
The aim of this study is to evaluate the efficiency of the Neuroestimulation of the Posterior Tibial Nerve for the treatment of this syndrome.
A multicentric, prospective, randomized study will be performed in patients affected with severe LARS symptoms. Patients will be randomized in two groups:
Hospital Universitari Vall d'Hebron Research Institute is the lead sponsor of 275 studies on the registry; 63 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Tibial nerve stimulation during 16 sessions
Device: Posterior tibial nerve stimulation
Sham tibial nerve stimulation during 16 sessions
Device: Sham posterior tibial nerve stimulation
Tibial nerve stimulation efficacy measured by LARS score
Time frame: 1 month
Tibial nerve stimulation efficacy measured by LARS score
Time frame: 3 months
Tibial nerve stimulation efficacy measured by LARS score
Time frame: 6 months
Tibial nerve stimulation efficacy measured by LARS score
Time frame: 12 months
This study is completed, as verified in Nov 2019. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hospital Universitari Vall d'Hebron Research Institute →